The Royal Marsden

Running trials

• Recruiting

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· Phase 3· Source

• Recruiting

  The Multicentre Selective Lymphadenectomy Trial - 3

  NCT07049276· Source

• Recruiting

  Ixovex-1 Single Agent and Combination Therapy

  NCT06549946· Phase 1/2· Source

• Active, not recruiting

  A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

  NCT05926765· Phase 2· Source

• Active, not recruiting

  Phase III Study of AK112 for NSCLC Patients

  NCT06396065· Phase 3· Source

• Active, not recruiting

  A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

  NCT05132582· Phase 3· Source

• Recruiting

  Study to Evaluate the Safety and Tolerability of EP0042

  NCT04581512· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer2 recruiting
• Acute myeloid leukemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Melanoma1 recruiting
• Myelodysplastic syndromes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Digital Body Mindset Intervention for Young Cancer Survivors

  NCT06702371· Source

• Terminated

  A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

  NCT05949632· Phase 1/2· Source

• Completed

  Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

  NCT05278975· Phase 1/2· Source

• Terminated

  A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

  NCT03281369· Phase 1/2· Source